Anti-tumour Screening of Brazilian Plants
Authors:
- Noel R. MonksNMNoel R. Monks
- Sergio A.L. BordignonSBSergio A.L. Bordignon
- Alexandre FerrazAFAlexandre Ferraz
- Katia R. MachadoKMKatia R. Machado
- Denise H. FariaDFDenise H. Faria
- Rafael M. LopesRLRafael M. Lopes
- Claudio A. MondinCMClaudio A. Mondin
- Izabel C.C. SouzaISIzabel C.C. Souza
- Martha F.S. LimaMLMartha F.S. Lima
- Adriana B. da RochaARAdriana B. da Rocha
- Gilberto SchwartsmannGSGilberto Schwartsmann
- 1 January 2002
- journal article
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 40 (8) , 603-616
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Scoring a bull's-eye against cancer genome targetsCurrent Opinion in Pharmacology, 2001
- Molecules for the millennium: how will they look? New drug discovery year 2000British Journal of Cancer, 2000
- Anti-Cancer Drug Discovery and Development in Brazil: Targeted Plant Collection as a Rational Strategy to Acquire Candidate Anti-Cancer CompoundsThe Oncologist, 2000
- Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USAAnnals of Oncology, 1999
- Paclitaxel (Taxol®): A success story with valuable lessons for natural product drug discovery and developmentMedicinal Research Reviews, 1998
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990